What is an Anti-SLA test?
The Anti-Soluble Liver Antigen (Anti-SLA) test is a blood test that detects autoantibodies against soluble liver antigen, also known as soluble liver antigen/liver-pancreas (SLA/LP) antibodies.
Anti-SLA antibodies are strongly associated with autoimmune hepatitis (AIH), a condition in which the immune system mistakenly attacks liver cells and causes ongoing liver inflammation.
Anti-SLA is considered a highly specific marker for autoimmune hepatitis, although it is found in only a proportion of patients. It can be particularly useful when other commonly tested autoimmune liver antibodies are negative.
What is the Anti-SLA test used for?
The test may be used to:
Support the diagnosis of autoimmune hepatitis
Investigate unexplained elevations of liver enzymes
Evaluate suspected autoimmune liver disease
Help identify autoimmune hepatitis when other autoantibodies are negative
Characterize the autoimmune antibody profile of a patient with suspected or established AIH
Anti-SLA is commonly interpreted together with other tests, including:
ANA – antinuclear antibodies
SMA/ASMA – smooth muscle antibodies
Anti-LKM-1 – liver-kidney microsomal type 1 antibody
Anti-LC1 – liver cytosol type 1 antibody
AMA – antimitochondrial antibodies
Total IgG
Liver function tests
Why do I need an Anti-SLA test?
Your healthcare provider may request this test if there are findings that suggest autoimmune hepatitis, such as:
Persistently elevated ALT or AST
Unexplained liver inflammation
Elevated total IgG
Jaundice
Fatigue
Abdominal discomfort
Abnormal liver function tests
Suspected autoimmune liver disease
Anti-SLA testing may be especially useful when the clinical picture suggests autoimmune hepatitis but other conventional autoantibodies are absent.
What happens during the test?
A small blood sample is collected from a vein in your arm.
The serum is analyzed using an immunological method to detect SLA/LP antibodies.
Depending on the laboratory method, the result may be reported as Positive/Negative, Detected/Not detected, or as a numerical antibody value with a laboratory-specific cutoff.
Will I need to do anything to prepare?
Usually, no fasting or special preparation is required.
Tell your healthcare provider about any known liver disease, autoimmune conditions, medications, and previous liver or autoimmune laboratory results.
Are there any risks?
The test involves a routine blood collection. You may experience minor discomfort, bruising, or tenderness at the collection site.
Serious complications are very uncommon.
What do the results mean?
Positive result
A positive Anti-SLA result means that antibodies against soluble liver antigen/liver-pancreas antigen were detected.
A positive Anti-SLA result provides strong supportive evidence for autoimmune hepatitis, particularly when accompanied by compatible clinical findings, elevated liver enzymes, and increased IgG.
Anti-SLA antibodies are considered highly specific for autoimmune hepatitis. However, a positive result should not be interpreted alone as a definitive diagnosis.
Further evaluation may include:
ALT and AST
Bilirubin and other liver tests
Total IgG
ANA, SMA, anti-LKM-1, and anti-LC1
Liver imaging when appropriate
Liver biopsy when clinically indicated
Negative result
A negative Anti-SLA result means that SLA/LP antibodies were not detected by the assay.
This does not exclude autoimmune hepatitis.
Anti-SLA is highly specific but is present in only a minority of patients with autoimmune hepatitis. Patients with AIH may instead have ANA, SMA, anti-LKM-1, or other antibody patterns—or may have no detectable conventional autoantibodies.
Therefore, a negative Anti-SLA result should be interpreted together with the patient's liver tests, IgG level, symptoms, and other diagnostic findings.
Important note about the results
Anti-SLA is one of the most specific serological markers associated with autoimmune hepatitis. Its detection can provide important diagnostic support, including in patients who are negative for more commonly tested antibodies such as ANA or SMA.
However, Anti-SLA should not be used as a stand-alone diagnostic test. The diagnosis of autoimmune hepatitis is based on a combination of clinical findings, biochemical evidence of liver inflammation, IgG levels, autoantibody results, exclusion of other causes of liver disease, and sometimes liver histology.
Anti-SLA antibodies may persist and can also be useful in characterizing patients with established autoimmune hepatitis.
The exact interpretation and positive cutoff depend on the assay method and manufacturer used by the laboratory. Results should therefore be interpreted according to the laboratory's validated reference criteria.
Prefer to talk to someone first? Contact us to book.
